GENDER-BASED ANALYSIS OF ADVERSE EFFECTS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES: A COMPARATIVE . (2025). Global Science Review, 2(1), 418-422. https://global-science-review.com/ojs/index.php/gsr/article/view/238